3,3'-Diindolylmethane Enhances Chemosensitivity of Multiple Chemotherapeutic Agents in Pancreatic Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-09-0838
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

3,3'-Diindolylmethane Enhances the Efficacy of Butyrate in Colon Cancer Prevention Through Down-Regulation of Survivin

Cancer Prevention Research
MedicineCancer ResearchOncology
2009English

3,3′-Diindolylmethane Enhances Glucose Uptake Through Activation of Insulin Signaling in 3t3-L1 Adipocytes

Obesity
NutritionEndocrinologyDieteticsMedicineMetabolismDiabetes
2018English

3,3′-Diindolylmethane: A Promising Sensitizer Ofγ-Irradiation

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2015English

JNK Suppression of Chemotherapeutic Agents-Induced ROS Confers Chemoresistance on Pancreatic Cancer Stem Cells

Oncotarget
Oncology
2014English

Correction To: Restoration of MARCKS Enhances Chemosensitivity in Cancer

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2020English

Retraction: Apoptosis-Inducing Effect of Erlotinib Is Potentiated by 3,3′-Diindolylmethane in Vitro and in Vivo Using an Orthotopic Model of Pancreatic Cancer

Molecular Cancer Therapeutics
Cancer ResearchOncology
2018English

Dichloroacetate Enhances the Antitumor Efficacy of Chemotherapeutic Agents via Inhibiting Autophagy in Non-Small-Cell Lung Cancer

Cancer Management and Research
Oncology
2018English

Targeting Claudin-4 Enhances CDDP-chemosensitivity in Gastric Cancer

Oncotarget
Oncology
2019English

A Selective Aryl Hydrocarbon Receptor Modulator 3,3'-Diindolylmethane Inhibits Gastric Cancer Cell Growth

Journal of Experimental and Clinical Cancer Research
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy